These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33402709)

  • 1. 2020 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2021 Feb; 20(2):85-90. PubMed ID: 33402709
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA's 'Accelerated Approvals' Are Critical But Raise Thorny Issues.
    Miller HI
    Mo Med; 2019; 116(3):168-169. PubMed ID: 31527930
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA new drug approvals in Q1 2021.
    Urquhart L
    Nat Rev Drug Discov; 2021 May; 20(5):334. PubMed ID: 33854219
    [No Abstract]   [Full Text] [Related]  

  • 4. 2010 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2011 Feb; 10(2):82-5. PubMed ID: 21283092
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug pipeline: 4Q17.
    DeFrancesco L
    Nat Biotechnol; 2018 Feb; 36(2):130. PubMed ID: 29406509
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory watch: FDA new drug approvals in Q1 2018.
    Urquhart L
    Nat Rev Drug Discov; 2018 Apr; 17(5):309. PubMed ID: 29700500
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA approval standards for anticancer agents - lessons from two recent approvals in breast cancer.
    Gyawali B; Kesselheim AS
    Nat Rev Clin Oncol; 2021 Jul; 18(7):397-398. PubMed ID: 33767454
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA: friend or foe?
    Lewis TS
    Med Device Technol; 1996 Nov; 7(9):24-30. PubMed ID: 10163675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose of reality for rational therapies.
    Nat Biotechnol; 2005 Mar; 23(3):267. PubMed ID: 15765066
    [No Abstract]   [Full Text] [Related]  

  • 10. Recap of FDA product approvals--2001.
    Traynor K
    Am J Health Syst Pharm; 2002 Feb; 59(4):321-2, 324. PubMed ID: 11885393
    [No Abstract]   [Full Text] [Related]  

  • 11. 2015 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2016 Feb; 15(2):73-6. PubMed ID: 26837582
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer chemotherapy: a rapidly moving train.
    Shader RI
    Clin Ther; 2013 Sep; 35(9):1253-4. PubMed ID: 24054701
    [No Abstract]   [Full Text] [Related]  

  • 13. Accelerated drug approval: FDA may get tougher; companies cite hurdles.
    Goozner M
    J Natl Cancer Inst; 2011 Mar; 103(6):455-7. PubMed ID: 21393609
    [No Abstract]   [Full Text] [Related]  

  • 14. Examining Manufacturing Readiness for Breakthrough Drug Development.
    Dye E; Sturgess A; Maheshwari G; May K; Ruegger C; Ramesh U; Tan H; Cockerill K; Groskoph J; Lacana E; Lee S; Miksinski SP
    AAPS PharmSciTech; 2016 Jun; 17(3):529-38. PubMed ID: 26608693
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA approvals for the first 6 months of 2016.
    Mullard A
    Nat Rev Drug Discov; 2016 Jul; 15(8):523. PubMed ID: 27469224
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA new drug approvals in Q3 2019.
    Urquhart L
    Nat Rev Drug Discov; 2019 Oct; 18(11):816. PubMed ID: 31673140
    [No Abstract]   [Full Text] [Related]  

  • 17. Difficult decisions.
    Nat Med; 2011 Aug; 17(8):901. PubMed ID: 21818065
    [No Abstract]   [Full Text] [Related]  

  • 18. Allen D. Rose.
    Rose AD
    Nat Rev Drug Discov; 2004 May; 3(5):382. PubMed ID: 15152630
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA accelerated approval benefits glioblastoma.
    Cloughesy T
    Lancet Oncol; 2010 Dec; 11(12):1120. PubMed ID: 21126686
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct-acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs.
    Mishra P; Murray J; Birnkrant D
    Hepatology; 2015 Oct; 62(4):1298-303. PubMed ID: 25953139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.